Steven Duncan Wood's most recent trade in MEI Pharma Inc was a trade of 3,100 Common Stock done at an average price of $3.2 . Disclosure was reported to the exchange on May 17, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
MEI Pharma Inc | Steven Duncan Wood | Director | Grant, award, or other acquisition of securities at price $ 3.17 per share. | 17 May 2024 | 3,100 | 4,359 (0%) | 0% | 3.2 | 9,827 | Common Stock |
MEI Pharma Inc | Wood Steven Duncan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
MEI Pharma Inc | Wood Steven Duncan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
MEI Pharma Inc | Steven Duncan Wood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 6,700 | 6,700 | - | - | Stock Option (Right to Buy) | |
MEI Pharma Inc | Duncan Steven Wood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 6,700 | 6,700 | - | - | Stock Option (Right to Buy) |